[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370696-105":59,"doc-detail-370696-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","exploring-the-oncogenic-roles-of-t-box-transcription-factor-tbx2-and-its-potential-as-a-therapeutic-target-review-article","Exploring the oncogenic roles of T-box transcription factor TBX2 and its potential as a therapeutic target - Review Article","","The T-box transcription factor TBX2 is a key regulator of embryonic development, controlling cell-fate decisions, migration, and tissue morphogenesis, and its reduced expression causes congenital heart and skeletal defects. TBX2 is frequently overexpressed in cancers, where it promotes proliferation, epithelial-to-mesenchymal transition, invasion, metastasis, and resistance to anti-cancer drugs. TBX2 represses tumour suppressor genes via complex co-repression mechanisms and cancer-linked signaling pathways such as Wnt/β-catenin and PI3K/AKT.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-the-oncogenic-roles-of-t-box-transcription-factor-tbx2-and-its-potential-as-a-therapeutic-target-review-article/370696/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-the-oncogenic-roles-of-t-box-transcription-factor-tbx2-and-its-potential-as-a-therapeutic-target-review-article/370696.png","ImageObject",300,407,{"name":92,"@type":93},"Nguyễn Văn Học","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",18,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What developmental processes does TBX2 regulate, and what happens when TBX2 levels drop?","Question",{"text":113,"@type":114},"TBX2 regulates cell-fate decisions, migration, and tissue morphogenesis. Reduced TBX2 levels result in developmental abnormalities including congenital heart and skeletal defects.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does TBX2 drive tumor progression in cancers?",{"text":118,"@type":114},"TBX2 overexpression functions as an oncogene, promoting senescence and cell-death pathway bypass, cell proliferation, epithelial-to-mesenchymal transition, invasion, and metastasis.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is TBX2 considered a potential therapeutic target?",{"text":122,"@type":114},"TBX2 transcriptionally represses multiple tumor suppressor genes and is linked to drug resistance and cancer-associated signaling pathways, suggesting targeting TBX2-dependent networks could improve therapeutic outcomes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},370696,1790491261,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","Biochemical Society Transactions (2025) 53 193–206 [https://doi.org/10.1042/BST20241069](https://doi.org/10.1042/BST20241069)  \nReview Article  \nExploring the oncogenic roles ofT-box transcription factor TBX2 and its potential asa therapeutic target  \nClaire Bellis*, Mihlali V. Mlaza*, Abid Ali, Amaal Abrahams and Sharon Prince  \nDivision of Cell Biology, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Observatory, 7925, Cape Town, South Africa Correspondence: Sharon Prince ([sharon.prince@uct.ac.za](sharon.prince@uct.ac.za))  \n*These authors contributed equally to this article.  \nReceived: 11 December 2024  \nRevised: 14 January 2025  \nAccepted: 21 January 2025  \nVersion of Record Published: 6 February 2025  \nDuring embryonic development, the T-box transcription factor TBX2 regulates key processes such as cell fate decisions, migration and tissue morphogenesis, and mutations that lead to reduced TBX2 levels result in developmental abnormalities including congenital heart and skeletal defects. TBX2, on the other hand, is overexpressed in a plethora of cancers where it functions as a powerful oncogene contributing to processes ranging from the bypass of senescence and cell death pathways to the promotion of cell proliferation, and epithelial-to-mesenchymal transition to drive invasion and metastasis. Additionally, TBX2 has been implicated in conferring resistance to anti-cancer drugs resulting in poor therapeutic outcomes. To exert its oncogenic functions, TBX2 transcriptionally represses key tumour suppressor genes involved in controlling cell proliferation and epithelial-to-mesenchymal transition such as p21Cip1, p14/p19ARF PTEN, NDRG1, CST6 and E-cadherin. This repression has been shown to involve complex mechanisms by which TBX2 co-opts transcription factors and recruits co-repression complexes to the promoters of these tumour suppressor genes. While limited information is available on how TBX2 is regulated in cancers, there is evidence that the levels and oncogenic functions of TBX2 are induced by developmental signalling pathways that are hijacked by cancer cells such as the Wnt/β-catenin and PI3K/AKT pathways. Understanding the complex molecular networks that TBX2 is involved in to exert its oncogenic functions is important because it may reveal potential therapeutic strategies for targeting TBX2 in TBX2-dependent cancers. This minireview discusses TBX2’s involvement in cancer signalling, its regulatory partners, and its impact on cancer progression and resistance to therapy.  \nIntroduction  \nThe evolutionarily conserved T-box family of transcription factors plays key roles in embryonic development and their deregulated expression result in developmental defects and diseases, especially cancer (Figure 1). They are divided into five subfamilies (T, TBX1, TBX2, TBX6 and TBr1), and 17 T-box genes have been identified in humans (Figure 1). All T-box factors share a common DNA-binding domain, called the T-box, and they function as either transcriptional activators or repressors with some factors capable of functioning as either one depending on cellular context [ 1–11] .  \nTBX2 is a member ofthe TBX2 subfamily which includes TBX3, TBX4 and TBX5 (Figure 1) . It was the first member ofthe T-box family to be identified in humans, and the TBX2 gene was cloned in  \n1995 [ 12] . TBX2 is located on chromosome 17q23, is 9.53 kb in length and has one coding transcript which contains 7 exons (Figure 2) . The TBX2 protein is 712 amino acids in length and contains the conserved T-box DNA-binding domain, an activation domain within the T-box, and a repression domain at the N-terminus and another at the C terminus (Figure 2) [3]. TBX2 can transcriptionally activate or repress its target genes through mechanisms involving its ability to bind T-box binding elements (T-elements) or other DNA sequences, such as E-box, EGR1 and Sp1 motifs (Figure 3) . Indeed, chromatin immunoprecipitation sequencing (ChIP-seq) c","cbCaifc8mnD6FCKx","https://ap.wps.com/l/cbCaifc8mnD6FCKx","pdf",2745911,14,"English","# Introduction\n## Roles of T-box transcription factors and TBX2\n## TBX2 gene, protein structure, and DNA-binding mechanisms\n## TBX2 in development and cancer biology","[{\"question\":\"What developmental processes does TBX2 regulate, and what happens when TBX2 levels drop?\",\"answer\":\"TBX2 regulates cell-fate decisions, migration, and tissue morphogenesis. Reduced TBX2 levels result in developmental abnormalities including congenital heart and skeletal defects.\"},{\"question\":\"How does TBX2 drive tumor progression in cancers?\",\"answer\":\"TBX2 overexpression functions as an oncogene, promoting senescence and cell-death pathway bypass, cell proliferation, epithelial-to-mesenchymal transition, invasion, and metastasis.\"},{\"question\":\"Why is TBX2 considered a potential therapeutic target?\",\"answer\":\"TBX2 transcriptionally represses multiple tumor suppressor genes and is linked to drug resistance and cancer-associated signaling pathways, suggesting targeting TBX2-dependent networks could improve therapeutic outcomes.\"}]","Exploring the oncogenic roles of T-box transcription factor TBX2 and its potential as a therapeutic target - Review Article | PDF",1790189888,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d508339ac091b90d209b7d209927cc5.webp",983,1301,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4d0625cac4d71bb18804bd62f25fe5c.webp",982,1299,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35e3725a37dbfa81033160264ca762da.webp",981,1298,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38dae33e45ceded97c266c1985539c61.webp",980,1297]